TRPV6 Determines the Effect of Vitamin D3 on Prostate Cancer Cell Growth
2011

TRPV6 and Vitamin D3's Role in Prostate Cancer Cell Growth

publication Evidence: moderate

Author Information

Author(s): Lehen'kyi V'yacheslav, Raphaël Maylis, Oulidi Agathe, Flourakis Matthieu, Khalimonchyk Sergii, Kondratskyi Artem, Gordienko Dmitri V., Mauroy Brigitte, Bonnal Jean-Lois, Skryma Roman, Prevarskaya Natalia

Primary Institution: Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France

Hypothesis

How do the antiproliferative effects of 1,25-dihydroxyvitamin D3 relate to the upregulation of the pro-oncogenic TRPV6 channel?

Conclusion

1,25-dihydroxyvitamin D3 enhances prostate cancer cell proliferation through TRPV6 channel upregulation.

Supporting Evidence

  • 1,25-dihydroxyvitamin D3 increased TRPV6 expression in low-steroid conditions.
  • TRPV6 knockdown reversed the pro-proliferative effects of 1,25-dihydroxyvitamin D3.
  • Calcium uptake was enhanced by TRPV6 in LNCaP cells treated with 1,25-dihydroxyvitamin D3.

Takeaway

Vitamin D3 can help prostate cancer cells grow more when a specific channel, TRPV6, is active.

Methodology

The study involved cell culture, RT-PCR, quantitative real-time PCR, western-blotting, and flow cytometry to analyze the effects of 1,25-dihydroxyvitamin D3 on prostate cancer cells.

Limitations

The study primarily focused on specific cell lines and may not fully represent all prostate cancer types.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016856

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication